Delta 9 Cannabis EBITDA
Cos'è EBITDA di Delta 9 Cannabis?
EBITDA di Delta 9 Cannabis Inc. è -CAD$11.41
Qual è la definizione di EBITDA?
L'EBITDA è il reddito di una società prima di interessi, imposte, deprezzamenti e ammortamenti ed è una misura contabile calcolata utilizzando gli utili netti di una società, prima che vengano sottratti interessi passivi, imposte, ammortamenti e ammortamenti come proxy della redditività corrente di un'azienda.
Although EBITDA is not a financial measure recognized in generally accepted accounting principles, it is widely used in many areas of finance when assessing the performance of a company, such as securities analysis. It is intended to allow a comparison of profitability between different companies, by discounting the effects of interest payments from different forms of financing (by ignoring interest payments), political jurisdictions (by ignoring tax), collections of assets (by ignoring depreciation of assets), and different takeover histories (by ignoring amortization often stemming from goodwill). EBITDA is a financial measurement of cash flow from operations that is widely used in mergers and acquisitions of small businesses and businesses in the middle market. It is not unusual for adjustments to be made to EBITDA to normalize the measurement allowing buyers to compare the performance of one business to another.
EBITDA di aziende nel Health Care settore su TSX rispetto a Delta 9 Cannabis
Cosa fa Delta 9 Cannabis?
Delta 9 Cannabis Inc. operates as an integrated cannabis company. The company, through its subsidiary, Delta 9 Bio-Tech Inc., engages in the cultivation, processing, extraction, wholesale distribution, retail, and sale of medical and recreational cannabis and related merchandise and devices. As of August 24, 2021, it owned and operated 13 retail stores under the Delta 9 brand name. Delta 9 Cannabis Inc. was founded in 2012 and is headquartered in Winnipeg, Canada.
Aziende con ebitda simili a Delta 9 Cannabis
- Experience Co ha EBITDA di -AUD$11.47
- Heidelberg Pharma AG ha EBITDA di -€11.45
- Guru Online () ha EBITDA di -HKD$11.45
- The Real Brokerage Inc ha EBITDA di -$11.45
- Phunware Inc ha EBITDA di -$11.44
- Marin Software Inc ha EBITDA di -$11.42
- Delta 9 Cannabis ha EBITDA di -CAD$11.41
- Skye Bioscience ha EBITDA di -$11.38
- MusclePharm ha EBITDA di -$11.38
- InfraStrata Plc ha EBITDA di -£11.38
- Camurus AB (publ) ha EBITDA di -kr11.38
- Orbite Technologies ha EBITDA di -CAD$11.38
- NorZinc ha EBITDA di -CAD$11.37